# Lumateperone Tosylate (Caplyta)

Source: https://ourhealthnetwork.com/drugs/lumateperone-tosylate
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Lumateperone Tosylate?

Lumateperone Tosylate (brand name: Caplyta) is an atypical antipsychotic. It is prescribed to treat schizophrenia. Across the United States, 3,000 doctors prescribe Lumateperone to approximately 3,000 Medicare patients.

## Brand names

Caplyta

## Indications

Lumateperone Tosylate is primarily prescribed for the treatment of schizophrenia.

## Conditions treated

- [Schizophrenia](https://ourhealthnetwork.com/conditions/schizophrenia)

## Mechanism of action

The mechanism of action of lumateperone for the treatment of schizophrenia in adults, for the treatment of depressive episodes associated with bipolar depression (as monotherapy or as adjunctive therapy with lithium or valproate), and as adjunctive therapy with antidepressants for the treatment of MDD is unknown. However, the mechanism of action of lumateperone for these uses could be mediated thr

## Drug classification

- Established Pharmacologic Class: Atypical Antipsychotic [EPC]
- Route of administration: ORAL

## Common side effects

somnolence/sedation and dry mouth

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)